Clearside Biomedical Inc [CLSD] stock prices are up 14.82% to $0.98 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CLSD shares have gain 9.83% over the last week, with a monthly amount drifted -0.24%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Clearside Biomedical Inc [NASDAQ: CLSD] stock has seen the most recent analyst activity on August 21, 2024, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $6. Previously, Oppenheimer started tracking the stock with Outperform rating on June 25, 2024, and set its price target to $5. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $10 on July 29, 2021. ROTH Capital initiated its recommendation with a Buy and recommended $8 as its price target on May 13, 2020. Needham downgraded its rating to Hold for this stock on August 09, 2019. In a note dated November 05, 2018, Stifel downgraded an Hold rating on this stock.
The stock price of Clearside Biomedical Inc [CLSD] has been fluctuating between $0.77 and $2.12 over the past year. Clearside Biomedical Inc [NASDAQ: CLSD] shares were valued at $0.98 at the most recent close of the market.
Analyzing the CLSD fundamentals
The Clearside Biomedical Inc [NASDAQ:CLSD] reported sales of 7.70M for trailing twelve months, representing a surge of 20.84%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -3.2%, Pretax Profit Margin comes in at -4.14%, and Net Profit Margin reading is -4.14%. To continue investigating profitability, this company’s Return on Assets is posted at -1.09, Equity is 1.27 and Total Capital is -1.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9100 points at the first support level, and at 0.8400 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0200, and for the 2nd resistance point, it is at 1.0600.
Ratios To Look Out For
It’s worth pointing out that Clearside Biomedical Inc [NASDAQ:CLSD]’s Current Ratio is 4.49. Also, the Quick Ratio is 4.49, while the Cash Ratio stands at 2.48. Considering the valuation of this stock, the price to sales ratio is 9.61.
Transactions by insiders
Recent insider trading involved Thorp Clay, Director, that happened on Feb 24 ’25 when 15000.0 shares were purchased. Chief Medical Officer, Chong Ngai Hang Victor completed a deal on Nov 01 ’24 to buy 36500.0 shares. Meanwhile, Chief Medical Officer Chong Ngai Hang Victor bought 23500.0 shares on Jun 24 ’24.
